Shubh Pharma Profile
Key Indicators
- Authorised Capital ₹ 6.70 M
as on 10-12-2024
- Paid Up Capital ₹ 0.42 M
as on 10-12-2024
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 162.91%
(FY 2023)
- Profit 534.00%
(FY 2023)
- Ebitda 23.62%
(FY 2023)
- Net Worth 45.69%
(FY 2023)
- Total Assets 40.74%
(FY 2023)
About Shubh Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.70 M and a paid-up capital of Rs 0.42 M, as per Ministry of Corporate Affairs (MCA) records.
Ashok Shinde and Pankaj Dhanu serve as directors at the Company.
- CIN/LLPIN
U24233MH2013PTC249401
- Company No.
249401
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Oct 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Shubh Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Shinde  | Director | 11-Jul-2022 | Current |
| Pankaj Dhanu | Director | 11-Jul-2022 | Current |
Financial Performance of Shubh Pharma.
Shubh Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 162.91% increase. The company also saw a substantial improvement in profitability, with a 534% increase in profit. The company's net worth Soared by an impressive increase of 45.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shubh Pharma?
Unlock access to Shubh Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- S M R Trading And Investment Company Private LimitedActive 44 years 2 months
Ashok Shinde is a mutual person
- Glamour Tin Industries Pvt LtdActive 41 years 7 months
Ashok Shinde and Pankaj Dhanu are mutual person
- K M R Trading Investment Company Private LimitedActive 44 years 2 months
Pankaj Dhanu is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shubh Pharma?
Unlock and access historical data on people associated with Shubh Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shubh Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shubh Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
